Market forces must prevail in Italy - Fracassi
This article was originally published in Clinica
Executive Summary
"Medtech supply prices must be free to develop in a transparent market and not through bureaucratic regulation." This is how Angelo Fracassi, president of industry federation Assobiomedica, responded to a government-hosted debate on the new reference-pricing system.